Allgemeines Krankenhaus Wien

Vienna A-1090

1 studies enrolling now · 8 studies all time

What they study most

Heart Defects, Congenital, Heart Diseases, Heart Failure, Leukemia Lymphocytic Chronic B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Neuroendocrine Tumors, Nonalcoholic Steatohepatitis, Primary Sclerosing Cholangitis, Soft Tissue Sarcoma

Studies at this site

• Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients — Running, not enrolling
• Global Utilization And Registry Database for Improved heArt preservatioN — Enrolling by invitation
• Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
• A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Completed
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma — Completed
• A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma — Completed